VANCOUVER, British Columbia, May 09, 2024 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed GMP psychedelics pharmaceutical manufacturer,
Acumen’s Phase II trial will eventually enroll around 540 people. Image credit: Shutterstock / PopTika. Acumen Pharmaceuticals has dosed the first patient in ALTITUDE-AD, a
Even with the recent awareness that clinical trials often lack the diversity that would make them representative, women and people of color remain underrepresented in
This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their
The restructuring plan was announced on the same day Takeda released its FY 2023 results. Image credit: Shutterstock/Tada Images. Takeda’s annual profits for FY 2023
The number of women participating in clinical trials is increasing in Africa. Credit: i_am_zews via Shutterstock. Despite more than 18% of the global population living
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Congratulations on
Latest data emphasises health gaps and the need for improvements in women’s health, particularly in preventive, emotional and pregnancy care.
Rise and shine, everyone, another busy day is on the way. We can tell because countless birds are chirping outside our window, the pace of
U.S. legislation that would sever ties with Chinese drugmakers would jeopardize the drug supply for millions of American patients if it’s passed, the biotechnology industry’s